International Products Corporation
Home  >  Events  >  3rd Annual Advances in Immuno-Oncology Congress, 24-25 May 2018, London, UK
3rd Annual Advances in Immuno-Oncology Congress, 24-25 May 2018, London, UK

3rd Annual Advances in Immuno-Oncology Congress, 24-25 May 2018, London, UK

Supplier: Oxford Global

Description

Following on from its huge success in 2017, Oxford Global are proud to present their 3rd Annual Advances in Immuno-Oncology Congress, 24-25 May, London, UK. This event will host over 300 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations and leading biotechnology companies

The worlds most leading authorities will give over 50 presentations across 6 interactive streams, including;

• Discovery of Immuno-Oncology Therapies
• Translational Immuno-Oncology
• Genomics in Cancer Immunotherapy and Precision Medicine
• Preclinical Development: Screening, Assays and Modelling in Immuno-Oncology
• Immuno-Oncology Therapeutics Approaches: Clinical Research and Clinical Trials
• Microbiome in Immuno-Oncology

Free Pre-Congress Live Webinars

Novel Checkpoint Inhibitors & Strategies for Combined Modality Treatment
Hosted by Geert Mudde, Founder and Chief Scientific Officer, TYG Oncology Ltd.

Register Here: http://bit.ly/2BeBVBc

Personalised Medicine and Immuno-Oncology
Hosted by Agnete Fredriksen, Chief Scientific Officer, Vaccibody.
Register Here: http://bit.ly/2BPiChe

For further information, prices & discounts please contact a.fernandez@oxfordglobal.co.uk or click here: http://bit.ly/2oJlVB7

Alternatively visit our website http://bit.ly/2kiJtbg
Button_on Button_off_labsave Button_off_labsave Button_off_labsave